news
Pfizer selects Exco InTouch’s novel eDiary technologies to initiate first ever Patient-Centered clinical trial
21 June 2011 | By The Scott Partnership
Exco InTouch, announced that its novel eDiary technologies have been selected by Pfizer...
List view / Grid view
Pfizer
news
Pfizer’s Lyrica top-line results positive in global Phase 3 Study
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...
news
Pfizer and Acura announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII
20 June 2011 | By Pfizer
Pfizer Inc. and Acura Pharmaceuticals Inc., announce the marketing approval from the U.S. FDA of OXECTATM (oxycodone HCl, USP) Tablets CII...
news
Greenphire Partners with Mytrus to provide web-based solutions
16 June 2011 | By The Scott Partnership
Greenphire, partners with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients...
news
Pfizer Injectables adds doxorubicin hydrochloride injection, USP to its portfolio of off-patent oncology products
15 June 2011 | By Pfizer
Pfizer Injectables, announced the addition of doxorubicin hydrochloride injection, USP...
news
Pfizer conducts first “virtual” clinical trial allowing patients to participate regardless of geography
9 June 2011 | By Pfizer Inc.
Pilot study will compare results to previous trial data to assess validity of new approach...
news
Pfizer and Hisun sign MOU to increase access to quality and low-cost medicines for patients in China
2 June 2011 | By
Pfizer Inc. and Zhejiang Hisun Pharmaceuticals jointly announced the signing of a MOU on their intention to establish a joint venture...
news
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
26 May 2011 | By ICON plc
ICON plc has announced a strategic partnership with Pfizer Inc...
news
Data supports efficacy of XIAPEX® (collagenase clostridium histolyticum)
26 May 2011 | By red healthcare communications
Data presented for the first time at the annual congress of the FESSH, further supports the role of XIAPEX®...
news
ELIQUIS® (apixaban) approved in Europe for preventing venous thromboembolism
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
news
Pfizer presents new Phase 3 data
18 May 2011 | By Pfizer
Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival...
news
Pfizer details new costs to settle some litigation
13 May 2011 | By European Pharmaceutical Review
Pfizer will settle more than 2,200 lawsuits alleging the company's Wyeth unit hid Prempro's cancer risks...
news
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
news
Pfizer’s Prevnar 13® meets all study endpoints in two pivotal phase 3 trials in adults aged 50 and older
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
news
The European Commission approves Pfizer’s Revatio® (sildenafil)
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
